Back to Market返回行情

214150.KQ CLASSYS Inc.

KOEHealthcare
₩45,900+0.77%LatestMarket Cap: ₩2.99T

As of 2026-08-09 03:24

Why 214150.KQ matters now

CLASSYS Inc. (214150.KQ) is a Korea stock in Healthcare. The latest InvestLog snapshot shows ₩45,900.00 with +0.77% on the session and ₩2.99T in market capitalization.

Valuation context is available even where detailed statement rows are sparse: InvestLog currently shows P/E 22.12, gross margin 74.7%, and operating margin 48.7%.

Valuation

P/E (TTM)

22.12

PEG

P/B

5.74

P/S

8.63

EV/EBITDA

16.93

DCF Value

FCF Yield

2.7%

Div Yield

0.6%

Margins & Returns

Gross Margin

74.7%

Operating Margin

48.7%

Net Margin

39.1%

ROE

26.0%

ROA

17.0%

ROIC

19.1%

Listing Info

Market

Korea

Exchange

KOE

Currency

KRW

Sector

Healthcare

Industry

Medical - Devices

Country

KR

CLASSYS Inc. is a global supplier of sophisticated medical aesthetic devices. Its diverse product range features SCIZER, a non-invasive solution for subcutaneous fat reduction; ULTRAFORMER MPT, which employs focused ultrasound stimulation for skin tissue coagulation to achieve eyebrow lifts; and ULTRAFORMER III, a high-intensity focused ultrasound (HIFU) surgical device designed for tissue coagulation, aiding in eyelid lifting, skin tightening, and improving subcutaneous tissue elasticity across the face (cheeks), abdomen, and thighs, while also diminishing crow's feet, laugh lines, and neck wrinkles. Additional offerings include INTRASURE, a versatile multi-platform solution for aesthetics and healthcare; FORSHAPE, an RF treatment system engineered to boost metabolism, enhance blood circulation, and facilitate tissue recovery; and VOLNEWMER, a monopolar radiofrequency therapeutic equipment used for skin tissue coagulation as a general electrosurgical instrument. The company's portfolio further encompasses CLATUU Alpha, a medical device that progressively reduces subcutaneous fat layers, particularly in areas of excessive accumulation, using low-temperature energy and negative pressure; Ulfit, which utilizes HIFU energy to improve skin elasticity and subcutaneous tissue in the abdomen and thighs; Refit, a medical device combining RF and negative pressure to elevate tissue temperature and blood flow, thereby alleviating pain in treated areas; AQUAPURE, equipped with four distinct handpieces for applications such as acne suction and various forms of pain relief, including muscle pain; and AQUAPURE II, a multi-functional device for comprehensive facial and body care. These products are marketed under the Classys, Cluederm, and SKEDERM brands. CLASSYS serves a broad client base, including clinics, hospitals, and beauty salons. The company was founded in 2007 and is headquartered in Seoul, South Korea.